Hans Biomed Corp banner
H

Hans Biomed Corp
KOSDAQ:042520

Watchlist Manager
Hans Biomed Corp
KOSDAQ:042520
Watchlist
Price: 40 000 KRW -8.88% Market Closed
Market Cap: ₩541.2B

Hans Biomed Corp
Investor Relations

Hans Biomed Corp. engages in the manufacture and sale of graft material and silicon products. The company is headquartered in Seoul, Seoul. The company went IPO on 2009-10-09. The firm mainly provides three categories of products: skin-implant materials, bone-implant materials and silicone products. Its skin-implant materials are used for burn treatment and skin graft under the brand names of SureDerm, BellaGen and GPS. Its bone-implant materials include allogeneic bones, xenogenous bones and synthetic bones used in dentistry, orthopedic and others, which are under the brand names of SureFuse, ExFuse and SureOss. Its silicone products are used for treatments of scars and for breast implant and others, which are under the brand names of BellaGel and Scar Clinic. In addition, it provides hair transplanters and others.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Seok-Bae Oh
Chief Financial Officer and Managing Director
No Bio Available
Mr. Won-Gyun Kwon
Senior MD & Director
No Bio Available
Guen Young Kim
Chief Executive Officer
No Bio Available

Contacts

Address
SEOUL
Seoul
7, Jeongui-ro 8-gil, Songpa-gu
Contacts
+8224662266
hansbiomed.com